Kinetics and Prediction of HBsAg Loss during Long-Term Therapy with Nucleos(t)ide Analogues of Different Potency in Patients with Chronic Hepatitis B

Open Access

Peer-reviewed

Research Article

Min-Ran Li,

Affiliation Department of Infectious Diseases, Peking University First Hospital, Beijing, China
⨯
Hong-Li Xi,

Affiliation Department of Infectious Diseases, Peking University First Hospital, Beijing, China
⨯
Qin-Huan Wang,

Affiliation Department of Infectious Diseases, Peking University First Hospital, Beijing, China
⨯
Feng-Qin Hou,

Affiliation Department of Infectious Diseases, Peking University First Hospital, Beijing, China
⨯
Na Huo,

Affiliation Department of Infectious Diseases, Peking University First Hospital, Beijing, China
⨯
Xia-Xia Zhang,

Affiliation Department of Infectious Diseases, Peking University First Hospital, Beijing, China
⨯
Fang Li,

Affiliation Department of Infectious Diseases, Peking University First Hospital, Beijing, China
⨯
Xiao-Yuan Xu

* E-mail: yangpin@public3.bta.net.cn

Affiliation Department of Infectious Diseases, Peking University First Hospital, Beijing, China
⨯

Reader Comments (0)

Antiviral therapy
Is the Subject Area "Antiviral therapy" applicable to this article?

Thanks for your feedback.
Hepatitis B virus
Is the Subject Area "Hepatitis B virus" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Hepatitis B
Is the Subject Area "Hepatitis B" applicable to this article?

Thanks for your feedback.
Viral persistence and latency
Is the Subject Area "Viral persistence and latency" applicable to this article?

Thanks for your feedback.
Cirrhosis
Is the Subject Area "Cirrhosis" applicable to this article?

Thanks for your feedback.
Liver diseases
Is the Subject Area "Liver diseases" applicable to this article?

Thanks for your feedback.
Serology
Is the Subject Area "Serology" applicable to this article?

Thanks for your feedback.